Syensqo SA/NV
ISIN: BE0974464977 | Ticker: SYENS | LEI: 549300060XNJ90PLNS10
Country: Belgium
At Syensqo, we’re explorers: experts in science and passionate about all its possibilities. Our innovative products and solutions help enhance the way people around the world live life every day: how they work, travel, and spend leisure time.
Inspired by the legacy of the Solvay Congresses, which brought together the greatest scientific minds to explore answers to the world’s biggest challenges, we strive to break new ground: addressing the critical needs of today and creating solutions for the future. We’re constantly expanding on what’s seemingly impossible and pushing the limits of what can be realized.
With a diverse global team of more than 13,000 employees in 30 countries, we work together to advance science and help humanity move forward.
2023
Served areaWorldwide
Headcount13,000
HeadquartersRue de la Fusee 98, 1130 Brussels – Belgium
| Date | Trading entity / Person | Association | Trade type | Volume |
|---|---|---|---|---|
| 10.04.24 | Kadri Ilham | Executive member | Buy | EUR 0.00 |
| 09.04.24 | Roger Davis Christopher | Executive member | Buy | EUR 0.00 |
| 28.03.24 | Boxus Joëlle | Executive member | Buy | EUR 0.00 |
| 27.03.24 | Tiberghien Hervé | Executive member | Buy | EUR 0.00 |
| 13.03.24 | Rollinger Mark | Executive member | Buy | EUR 50,155.58 |
| 25.01.24 | Tiberghien Hervé | Executive member | Buy | EUR 80,385.30 |
| 22.01.24 | Roger Davis Christopher | Executive member | Buy | EUR 100,147.73 |
| 19.01.24 | Kadri Ilham | Executive member | Buy | EUR 495,972.72 |
| 18.01.24 | Kadri Ilham | Executive member | Buy | EUR 505,663.32 |
BE0974464977
LEI549300060XNJ90PLNS10
SectorPharmaceuticals, Biotechnology & Life Sciences
IndustryKeep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.